Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage
Authors
Keywords
Kidneys, Fibrosis, Obesity, Chronic kidney disease, Inflammation, Albumins, Collagens, Urine
Journal
PLoS One
Volume 11, Issue 11, Pages e0166272
Publisher
Public Library of Science (PLoS)
Online
2016-11-10
DOI
10.1371/journal.pone.0166272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diet-induced obesity and kidney disease – In search of a susceptible mouse model
- (2016) Shawna E. Wicks et al. BIOCHIMIE
- Galectin-3 inhibition prevents adipose tissue remodelling in obesity
- (2016) E Martínez-Martínez et al. INTERNATIONAL JOURNAL OF OBESITY
- Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and HypertensionNovelty and Significance
- (2015) Ernesto Martínez-Martínez et al. HYPERTENSION
- Galectin-3 Participates in Cardiovascular Remodeling Associated With ObesityNovelty and Significance
- (2015) Ernesto Martínez-Martínez et al. HYPERTENSION
- Reversibility of chronic kidney disease and outcomes following aortic valve replacement
- (2015) Marc Najjar et al. Interactive Cardiovascular and Thoracic Surgery
- The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
- (2015) Laurent Calvier et al. JACC-Heart Failure
- Elevated Galectin-3 Precedes the Development of CKD
- (2013) C. M. O'Seaghdha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
- (2013) Peter G. Traber et al. PLoS One
- Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival
- (2011) W.H. Wilson Tang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
- (2011) Alison C. MacKinnon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Epithelial-mesenchymal transition in renal fibrosis - evidence for and against
- (2011) Maria Fragiadaki et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
- (2011) Maria Kolatsi-Joannou et al. PLoS One
- Epithin, a target of transforming growth factor-β signaling, mediates epithelial–mesenchymal transition
- (2010) Hyo Seon Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanisms of Tubulointerstitial Fibrosis
- (2010) M. Zeisberg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults
- (2009) S. Anderson et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
- (2009) Y. Liu JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement
- (2009) F. Aregger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
- (2008) Neil C. Henderson et al. AMERICAN JOURNAL OF PATHOLOGY
- A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury
- (2008) Ana Paula Fernandes Bertocchi et al. TRANSPLANT INTERNATIONAL
- Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model
- (2008) Hai-Ying Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started